Top Institutions in Ophthalmology - Retina
Leading academic medical centers with strong ophthalmology departments and active participation in large collaborative networks like the DRCR Retina Network and NIH-funded AI research projects are recognized for their expertise. These institutions contribute through clinical trials, data sharing, and innovation in retinal disease management.
-
#1
Byers Eye Institute at Stanford University
Palo Alto, CA
Home to Dr. Diana V. Do, a leader in retina clinical affairs and editor-in-chief of Retinal Physician, Stanford is deeply involved in retina research and clinical trials, fostering collaboration and innovation in retinal disease management.
Key Differentiators
- Ophthalmology
- Retina
- Clinical Research
-
#2
University of Washington
Seattle, WA
A key site for the NIH-funded AI-READI project, the University of Washington contributes significant expertise in multimodal data collection and AI applications in diabetic eye disease research.
Key Differentiators
- Ophthalmology
- Retina
- AI in Ophthalmology
-
#3
University of California, San Diego
San Diego, CA
UC San Diego is a major participant in collaborative retina research initiatives, including the AI-READI project, and contributes to clinical trials evaluating novel treatments for retinal diseases.
Key Differentiators
- Ophthalmology
- Retina
- Clinical Trials
-
#4
University of Alabama at Birmingham
Birmingham, AL
As a recruitment site for the AI-READI project, UAB plays an important role in collecting standardized data for diabetic eye research and advancing AI applications in ophthalmology.
Key Differentiators
- Ophthalmology
- Retina
- Clinical Research
-
#5
DRCR Retina Network
Multiple (Network), Multiple
A pioneering collaborative research network uniting retina specialists and researchers nationwide, the DRCR Retina Network has revolutionized diabetic macular edema management and continues to conduct pivotal clinical trials.
Key Differentiators
- Retina
- Clinical Trials
- Collaborative Research
This content is an AI-generated, fully rewritten summary based on a published scholarly article. It does not reproduce the original text and is not a substitute for the original publication. Readers are encouraged to consult the source for full context, data, and methodology.







